Using advanced computer techniques to design and understand proteins and their interactions
Molecular modeling and machine learning for protein structures and interactions
This study is exploring how proteins are built and how they work together, with the goal of finding new ways to treat autoimmune diseases and cancers, so patients can look forward to better therapies in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11094687 on NIH RePORTER |
What this research studies
This research focuses on utilizing structural biology, molecular simulations, and machine learning to create new protein structures and predict how proteins interact with each other. By designing stable protein scaffolds, the research aims to enhance our understanding of protein folding and improve biomedical applications. Additionally, it investigates how the adaptive immune system distinguishes between self and non-self proteins, which is crucial for understanding autoimmune diseases and cancers. Patients may benefit from insights gained through this research, which could lead to innovative therapies and treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases or cancers who may benefit from novel therapeutic approaches.
Not a fit: Patients with conditions unrelated to protein interactions or those not affected by autoimmune diseases or cancers may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for autoimmune diseases and cancers by improving our understanding of protein interactions.
How similar studies have performed: Other research has shown success in using molecular modeling and machine learning to advance our understanding of protein interactions, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Bradley, Philip — Fred Hutchinson Cancer Center
- Study coordinator: Bradley, Philip
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.